| Upper gastrointestinal bleeding associated with the use of NSAIDs: newer versus older agents JR Laporte, L Ibanez, X Vidal, L Vendrell, R Leone Drug safety 27, 411-420, 2004 | 615 | 2004 |
| Principios de epidemiología del medicamento JR Laporte | 558 | 2007 |
| Upper gastrointestinal bleeding in relation to previous use of analgesics and non-steroidal anti-inflammatory drugs JR Laporte, X Carne, X Vidal, V Moreno, J Juan The Lancet 337 (8733), 85-89, 1991 | 438 | 1991 |
| Dose–response relationships between individual nonaspirin nonsteroidal anti‐inflammatory drugs (NANSAIDs) and serious upper gastrointestinal bleeding: a meta‐analysis based on … SC Lewis, MJS Langman, JR Laporte, JNS Matthews, MD Rawlins, ... British journal of clinical pharmacology 54 (3), 320-326, 2002 | 334 | 2002 |
| Population-based drug-induced agranulocytosis L Ibáñez, X Vidal, E Ballarín, JR Laporte Archives of internal medicine 165 (8), 869-874, 2005 | 295 | 2005 |
| Principios básicos de investigación clínica JR Laporte | 294 | 2006 |
| Epidemiology of aplastic anemia: a prospective multicenter study E Montané, L Ibáñez, X Vidal, E Ballarín, R Puig, N García, JR Laporte Haematologica 93 (4), 518-523, 2008 | 267 | 2008 |
| Agranulocytosis associated with dipyrone (metamizol) L Ibanez, X Vidal, E Ballarín, JR Laporte European journal of clinical pharmacology 60, 821-829, 2005 | 237 | 2005 |
| Upper gastrointestinal bleeding associated with antiplatelet drugs L Ibanez, X Vidal, L Vendrell, U Moretti, JR Laporte, ... Alimentary pharmacology & therapeutics 23 (2), 235-242, 2006 | 204 | 2006 |
| Preliminary efficacy and safety of an oromucosal standardized cannabis extract in chemotherapy‐induced nausea and vomiting M Duran, E Pérez, S Abanades, X Vidal, C Saura, M Majem, E Arriola, ... British journal of clinical pharmacology 70 (5), 656-663, 2010 | 198 | 2010 |
| Estudios de utilización de medicamentos y de farmacovigilancia JR Laporte, G Tognoni Principios de epidemiología del medicamento 2 (1), 24, 1993 | 176 | 1993 |
| Oral antispastic drugs in nonprogressive neurologic diseases: a systematic review E Montané, A Vallano, JR Laporte Neurology 63 (8), 1357-1363, 2004 | 173 | 2004 |
| Drug utilization studies: a tool for determining the effectiveness of drug use. JR Laporte, M Porta, D Capella British journal of clinical pharmacology 16 (3), 301-304, 1983 | 168 | 1983 |
| Prospective surveillance of acute serious liver disease unrelated to infectious, obstructive, or metabolic diseases: epidemiological and clinical features, and exposure to drugs L Ibáñez, E Pérez, X Vidal, JR Laporte Journal of hepatology 37 (5), 592-600, 2002 | 157 | 2002 |
| Multicenter study on self‐medication and self‐prescription in six Latin American countries Drug Utilization Research Group, Latin America, ... Clinical Pharmacology & Therapeutics 61 (4), 488-493, 1997 | 151 | 1997 |
| Métodos aplicados en estudios descriptivos de utilización de medicamentos D Capellà, JR Laporte Principios de epidemiología del medicamento 2, 67-93, 1993 | 141 | 1993 |
| β-Adrenergic blocking agents in heart failure: Benefits of vasodilating and nonvasodilating agents according to patients' characteristics: A meta-analysis of clinical trials S Bonet, A Agustí, JM Arnau, X Vidal, E Diogene, E Galve, JR Laporte Archives of Internal Medicine 160 (5), 621-627, 2000 | 131 | 2000 |
| End‐stage renal disease and non‐narcotic analgesics: a case‐control study. M Morlans, JR Laporte, X Vidal, D Cabeza, PD Stolley British journal of clinical pharmacology 30 (5), 717-723, 1990 | 131 | 1990 |
| Bovine gangliosides and acute motor polyneuropathy. A Figueras, FJ Morales-Olivas, D Capella, V Palop, JR Laporte BMJ: British Medical Journal 305 (6865), 1330, 1992 | 95 | 1992 |
| Promoción del uso racional de los medicamentos y preparación de guías farmacológicas JM Arnau, JR Laporte Laporte JR, Tognoni G. Principios de epidemiología del medicamento. 2ª ed …, 1993 | 93 | 1993 |
